Organic Acids (Urine): Which Tests to Order Alongside for a Complete Metabolic Picture

What Does a Urine Organic Acids Test Actually Measure?

Organic acids are water-soluble intermediates generated during amino acid catabolism, fatty acid oxidation, carbohydrate metabolism, and neurotransmitter turnover. Gas chromatography-mass spectrometry (GC-MS) separates and quantifies these compounds from a single urine specimen. The American College of Medical Genetics and Genomics (ACMG) considers urine organic acid analysis a first-tier diagnostic tool for evaluating suspected inborn errors of metabolism in both pediatric and adult populations 1.

A single OAT run can flag more than 70 analytes. That breadth is its strength and its limitation. Elevated adipic acid, for instance, could signal a fatty acid oxidation defect, prolonged fasting, or simply a high-fat meal the night before collection. Without confirmatory data from blood-based assays, an abnormal organic acid result remains a hypothesis rather than a diagnosis. The ACMG's 2013 practice guideline states: "Urine organic acid analysis should be interpreted in the context of concurrent plasma amino acid and acylcarnitine profiles" 1.

Specimen handling matters. Bacterial overgrowth in an unpreserved sample generates artifactual peaks (particularly D-lactic acid and phenylacetic acid) that mimic metabolic disease. Freeze the sample within 30 minutes of void, ship on dry ice, and document any antibiotic or antifungal use within the prior two weeks 2.

The Core Companion Panel: Plasma Amino Acids

Plasma amino acids are the single most important add-on. Organic acids show downstream metabolites; amino acids show the upstream substrates. Together they triangulate. If 3-methylglutaconic acid is elevated on OAT but leucine and isoleucine are normal on a fasting amino acid panel, you can deprioritize a branched-chain amino acid oxidation defect and look instead at mitochondrial membrane dysfunction 3.

Timing alignment is non-negotiable. Draw the amino acid specimen within 2 hours of the organic acid collection, both fasting. The ACMG recommends a minimum 8-hour fast for plasma amino acids in patients older than one year 1. A fed-state amino acid panel introduces postprandial noise (especially elevated branched-chain amino acids) that directly confounds OAT interpretation.

Reference intervals vary by age. Neonates show physiologically higher glycine and proline concentrations. For adults, most reference labs report total plasma amino acid concentrations between 2.5 and 4.5 mmol/L, though individual analyte ranges differ substantially 4.

Acylcarnitine Profile: The Fatty Acid Oxidation Checkpoint

The acylcarnitine profile, drawn from a dried blood spot or plasma, evaluates carnitine-conjugated intermediates of fatty acid beta-oxidation and select amino acid pathways. In a 2020 retrospective analysis of 4,049 patients referred for metabolic workup, combining OAT with acylcarnitine profiling increased diagnostic sensitivity for fatty acid oxidation disorders from 71% (OAT alone) to 94% 5.

Order it whenever OAT shows elevated suberic acid, sebacic acid, or medium-chain dicarboxylic acids. These findings suggest impaired beta-oxidation but cannot distinguish medium-chain acyl-CoA dehydrogenase deficiency (MCADD) from long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD) without the acylcarnitine data. MCADD, the most common fatty acid oxidation disorder, affects approximately 1 in 17,000 newborns in populations of Northern European descent 6.

Free and total carnitine should be included. A low free carnitine (<20 µmol/L) with elevated acylcarnitines points toward secondary carnitine depletion, which itself changes supplementation decisions.

Methylmalonic Acid and Homocysteine: The B12-Folate Axis

Methylmalonic acid (MMA) in serum confirms what OAT suggests. When urine methylmalonate is elevated, serum MMA distinguishes true B12-dependent methylmalonic acidemia from renal concentrating effects or mild dehydration artifacts. Serum MMA above 0.4 µmol/L in the setting of elevated urine methylmalonate strongly supports functional B12 deficiency or a genetic defect in cobalamin metabolism 7.

Homocysteine fills the other half of the picture. B12 and folate both feed the methionine synthase reaction. Elevated homocysteine (above 15 µmol/L) with normal MMA suggests isolated folate deficiency. Elevated homocysteine with elevated MMA points toward B12 deficiency or combined B12/folate depletion. A 2017 systematic review across 14 observational studies (pooled N = 8,912) confirmed that the MMA-homocysteine pair correctly classified the deficient vitamin in 89% of cases when both analytes were available, compared with 64% when clinicians relied on serum B12 alone 8.

Dr. Sally Stabler, professor of medicine at the University of Colorado, wrote in a 2013 review for the New England Journal of Medicine: "Serum vitamin B12 levels can be normal in up to 50% of patients with true tissue-level deficiency; metabolic markers are required for reliable diagnosis" 9.

Comprehensive Metabolic Panel and CBC

A comprehensive metabolic panel (CMP) is baseline infrastructure. It is cheap, fast, and it contextualizes OAT findings in three ways. First, renal function: a creatinine above 1.5 mg/dL alters organic acid clearance and makes urine concentrations unreliable without normalization. Second, liver transaminases: elevated AST/ALT alongside elevated fumarate and malate on OAT raises suspicion for mitochondrial hepatopathy rather than a primary TCA cycle defect. Third, glucose and CO2: low bicarbonate with high anion gap plus elevated lactate on OAT constitutes a metabolic emergency, not an outpatient workup.

A complete blood count (CBC) adds one more data point. Macrocytic anemia (MCV above 100 fL) corroborates the functional B12 or folate deficiency suggested by elevated MMA or formiminoglutamic acid (FIGLU) on OAT. Neutrophil hypersegmentation on the peripheral smear is another early sign 10.

Nutrient Cofactor Levels: B2, B6, and CoQ10

OAT markers of cofactor insufficiency are indirect. Elevated glutaric acid and 2-hydroxyglutaric acid may reflect riboflavin (B2) deficiency, but they also appear in glutaric acidemia type I (a genetic condition with a prevalence of roughly 1 in 100,000). To differentiate, measure erythrocyte glutathione reductase activity coefficient (EGRAC), where values above 1.4 indicate B2 depletion 11.

Pyridoxal 5'-phosphate (PLP), the active form of B6, should be measured whenever OAT shows elevated xanthurenic acid or kynurenic acid. These tryptophan catabolites accumulate when B6-dependent kynureninase activity is impaired. The Endocrine Society does not publish formal B6 testing guidelines, but the Linus Pauling Institute at Oregon State University considers plasma PLP below 30 nmol/L as insufficient for non-pregnant adults 12.

CoQ10 (ubiquinone) assessment pairs with OAT findings of elevated succinate-to-fumarate ratios. Measure serum CoQ10; levels below 0.5 µg/mL warrant further mitochondrial evaluation, particularly in patients presenting with myopathy or exercise intolerance.

Lactate, Pyruvate, and the Lactate-to-Pyruvate Ratio

Elevated urine lactate on OAT prompts a venous blood lactate draw. The distinction between a collection artifact and genuine lactic acidosis depends on a properly collected, free-flowing venous sample processed within 15 minutes. Venous lactate above 2.2 mmol/L, confirmed on repeat, merits investigation.

The lactate-to-pyruvate (L:P) ratio further classifies the defect. An L:P ratio above 25 suggests impaired oxidative phosphorylation (respiratory chain defects). An L:P ratio below 25 with elevated lactate points toward pyruvate dehydrogenase deficiency or gluconeogenic disorders 13. Dr. Salvatore DiMauro of Columbia University noted in a landmark 2004 review: "The L:P ratio remains the simplest bedside tool for differentiating mitochondrial from non-mitochondrial causes of lactic acidosis" 14.

Pyruvate is notoriously labile. Collect in a perchloric acid tube, keep on ice, and deliver to the lab within 30 minutes. Delay invalidates the ratio.

Genetic Confirmation: When to Escalate

An abnormal OAT finding that persists on repeat testing, is confirmed by the paired blood panels described above, and does not respond to cofactor supplementation requires genetic testing. Whole-exome sequencing (WES) or targeted gene panels (such as the Invitae Comprehensive Metabolic Disorders Panel covering 217 genes) can identify pathogenic variants in enzymes responsible for organic acid accumulation.

The ACMG recommends that molecular confirmation precede any long-term dietary restriction or cofactor mega-dosing protocol 1. A 2021 study found that among 312 children initially flagged by OAT, only 38% received a confirmed genetic diagnosis after full workup, while 44% were attributed to transient or dietary causes 15.

Do not start carnitine supplementation at pharmacologic doses (100 mg/kg/day) in a patient with suspected but unconfirmed long-chain fatty acid oxidation defects. In VLCADD, excessive carnitine loading can generate toxic long-chain acylcarnitines.

How to Interpret Normal Ranges

There is no single "normal organic acids level" because the test measures dozens of analytes, each with its own reference interval. Most reference labs report results as micromoles per mole of creatinine (µmol/mol creatinine) to account for urine concentration variability. For example, Genova Diagnostics reports urine methylmalonate reference ranges of 0.3 to 3.6 mmol/mol creatinine for adults, while suberic acid reference ranges fall between 0.1 and 3.3 mmol/mol creatinine 2.

Age, diet, medication, and hydration status all shift individual analyte concentrations. A "high" single marker is rarely actionable. Clinicians should look for patterns: multiple elevated markers within the same metabolic pathway carry more diagnostic weight than a single outlier. Two or three converging elevations across OAT, amino acids, and acylcarnitines constitute a pattern worth pursuing.

Collection Protocol and Pre-Analytic Variables

First morning void is preferred for spot collections. Patients should fast for 10 to 12 hours before collection (water permitted). Discontinue biotin supplements at least 72 hours before specimen collection, as biotin-dependent carboxylase substrates (3-hydroxyisovaleric acid, 3-methylcrotonylglycine) are directly affected.

Medications that alter OAT results include valproic acid (elevates 3-hydroxy-3-methylglutaric acid), aspirin (elevates 2-hydroxyhippuric acid), and acetaminophen (produces a 5-oxoproline peak that mimics glutathione synthesis defects) 16. Document all supplements and prescriptions on the requisition form.

Arabinose and tartaric acid elevations on OAT are sometimes attributed to intestinal yeast overgrowth, but a 2019 review in Clinical Chemistry found "insufficient evidence to support the use of urine D-arabinitol as a standalone marker for invasive candidiasis" 17. If fungal overgrowth is suspected, pair with stool GI-MAP or serum beta-D-glucan rather than relying on the OAT marker alone.